Moderate- and High-Intensity Endurance Training Alleviate Diabetes-Induced Cardiac Dysfunction in Rats
Nutrients · 12.09.2023 · 15 (18) · 3950
DOI: 10.3390/nu15183950 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, online erschienen am 12.09.2023. Verfasst von Sarah D'Haese und 7 weiteren Autor:innen. Beteiligte Einrichtung: UHasselt, Cardio & Organ Systems (COST), Biomedical Research Institute, Agoralaan, 3590 Diepenbeek, Belgium. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Insulin Resistance, Endurance Training, Heart Diseases. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bijzonder onderzoeksfonds (BOF).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Exercise training is an encouraging approach to treat cardiac dysfunction in type 2 diabetes (T2DM), but the impact of its intensity is not understood. We aim to investigate whether and, if so, how moderate-intensity training (MIT) and high-intensity interval training (HIIT) alleviate adverse cardiac remodeling and dysfunction in rats with T2DM. Male rats received standard chow (n = 10) or Western diet (WD) to induce T2DM. Hereafter, WD rats were subjected to a 12-week sedentary lifestyle (n = 8), running MIT (n = 7) or HIIT (n = 7). Insulin resistance and glucose tolerance were assessed during the oral glucose tolerance test. Plasma advanced glycation end-products (AGEs) were evaluated. Echocardiography and hemodynamic measurements evaluated cardiac function. Underlying cardiac mechanisms were investigated by histology, western blot and colorimetry. We found that MIT and HIIT lowered insulin resistance and blood glucose levels compared to sedentary WD rats. MIT decreased harmful plasma AGE levels. In the heart, MIT and HIIT lowered end-diastolic pressure, left ventricular wall thickness and interstitial collagen deposition. Cardiac citrate synthase activity, mitochondrial oxidative capacity marker, raised after both exercise training modalities. We conclude that MIT and HIIT are effective in alleviating diastolic dysfunction and pathological cardiac remodeling in T2DM, by lowering fibrosis and optimizing mitochondrial capacity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- UHasselt, Cardio & Organ Systems (COST), Biomedical Research Institute, Agoralaan, 3590 Diepenbeek, Belgium.
- Department of Internal Medicine, CARIM School for Cardiovascular Diseases, Maastricht University Medical Centre, Universiteitssingel 50, 6229 ER Maastricht, The Netherlands.
- UHasselt, SMRC Sports Medical Research Center, Agoralaan, 3590 Diepenbeek, Belgium.
- Division of Sport Science, Faculty of Medicine & Health Sciences, Stellenbosch University, Stellenbosch 7602, South Africa.
- UHasselt, REVAL Rehabilitation Research Centre, Faculty of Rehabilitation Sciences, Agoralaan, 3590 Diepenbeek, Belgium.
- Department of Cardiology, Heart Centre Hasselt, Jessa Hospital, Stadsomvaart 11, 3500 Hasselt, Belgium.
ORCID-Profile: Sarah D'Haese, Ivo Lambrichts, Virginie Bito
Förderung
- Bijzonder onderzoeksfonds (BOF)
Zitieren
APA
D'Haese, S., Verboven, M., Evens, L., Deluyker, D., Lambrichts, I., Eijnde, B. O., Hansen, D., & Bito, V. (2023). Moderate- and High-Intensity Endurance Training Alleviate Diabetes-Induced Cardiac Dysfunction in Rats. Nutrients, 15(18), 3950. https://doi.org/10.3390/nu15183950
Vancouver
D'Haese S, Verboven M, Evens L, Deluyker D, Lambrichts I, Eijnde BO, et al. Moderate- and High-Intensity Endurance Training Alleviate Diabetes-Induced Cardiac Dysfunction in Rats. Nutrients. 2023;15(18):3950. doi:10.3390/nu15183950
BibTeX
@article{DHaese2023,
author = {D'Haese, Sarah and Verboven, Maxim and Evens, Lize and Deluyker, Dorien and Lambrichts, Ivo and Eijnde, B O and Hansen, Dominique and Bito, Virginie},
title = {Moderate- and High-Intensity Endurance Training Alleviate Diabetes-Induced Cardiac Dysfunction in Rats},
journal = {Nutrients},
year = {2023},
volume = {15},
number = {18},
pages = {3950},
doi = {10.3390/nu15183950}
}
EUVIMED